Oral News and Research

RSS

Ardelyx reports net income of $9.0 million for second quarter 2015

Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, today announced financial results for the second quarter ended June 30, 2015.

12 Aug 2015

Findings may lead to more accurate diagnostic test, possible vaccine for oral and genital herpes

Findings from a pair of new studies could speed up the development of a universally accurate diagnostic test for human herpes simplex viruses, according to researchers at Johns Hopkins and Harvard universities and the National Institutes of Health.

12 Aug 2015

Study finds no added benefit for insulin degludec and liraglutide in type 2 diabetes

The fixed-ratio combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since September 2014 for adults with type 2 diabetes mellitus. It is given as an injection in addition to other blood-glucose lowering drugs when these alone or in combination with basal insulin are insufficient to lower blood glucose levels.

12 Aug 2015

Griffith research aims to combat tooth decay problems in Australian children

Tooth decay in children is a major problem across Australia, especially so in rural, remote and Indigenous communities. Children in the Northern Peninsula Area have a particular problem partly because the plant to add fluoride to the water system is no longer in use.

11 Aug 2015

IADR/AADR reports include critical review of diet, dental caries and health policy interventions

Today, the International and American Associations for Dental Research (IADR/AADR) published two reports including a critical review titled "Diet and Dental Caries - the Pivotal Role of Free Sugars Reemphasized."

11 Aug 2015

Meta-analysis confirms oral contraceptives reduce endometrial cancer risk

Oral contraceptive use protects against endometrial cancer, with effects persisting for decades after cessation of use, shows a meta-analysis of individual patient data published in The Lancet Oncology.

10 Aug 2015

Instrumentation Laboratory announces European release of HemosIL Rivaroxaban Testing Solution

Instrumentation Laboratory today announced the commercialization of their HemosIL Rivaroxaban Testing Solution in Europe. The HemosIL Liquid Anti-Xa assay, when used in conjunction with HemosIL Rivaroxaban Calibrators and HemosIL Rivaroxaban controls offers an automated solution for measurement of rivaroxaban.

10 Aug 2015

Flowonix Medical's new Patient Therapy Controller approved for market release

Flowonix Medical, Inc., announced today that its newest product, the Patient Therapy Controller (PTC), has been approved for market release. The PTC interfaces with the company's Prometra platform of intrathecal infusion devices. A small, hand-held device with a touch-screen, the PTC allows the patient to initiate a bolus delivery of medication from the implanted pump.

7 Aug 2015

Lexicon Pharmaceuticals' revenues decrease to $0.4 million in second quarter 2015

Lexicon Pharmaceuticals, Inc., today reported financial results for the second quarter ended June 30, 2015 and provided an overview of key milestones for the company's lead drug candidates.

7 Aug 2015

Passionate kissing not the norm in most cultures, research finds

For generations, passionate kisses immortalized in movies, songs and the arts have served as a thermometer of romantic affection.

7 Aug 2015

Researcher reveals link between inflammatory response of neutrophils and spread of oral cancer

An abnormal immune response or "feedback loop" could very well be the underlying cause of metastases in oral cancers, according to Dr. Marco Magalhaes, Assistant Professor at the University of Toronto's Faculty of Dentistry and lead researcher in a study published in the journal Cancer Immunology Research.

7 Aug 2015

Study sheds light on Avoidant/Restrictive Food Intake Disorder

When most people think of eating disorders, they think of anorexia nervosa and bulimia nervosa. But there's another condition that has nothing to do with concerns over weight, shape or body image, and it has been recognized in the latest edition of the Diagnostic and Statistical Manual of Mental Disorders, which doctors use to diagnose conditions.

7 Aug 2015

Investigational topical drug shows promise in patients with early stage cutaneous T cell lymphoma

Results of a phase one trial show that an investigational topical drug, resiquimod gel, causes regression of both treated and untreated tumor lesions and may completely remove cancerous cells from both sites in patients with early stage cutaneous T cell lymphoma (CTCL) - a rare type of non-Hodgkin lymphoma that affects the skin.

7 Aug 2015

Grant program aims to provide oral health care to underserved people facing substance abuse issues

People with drug problems don't often come to mind as an underserved population regarding health care. Yet, because of their substance abuse issues, they often go without essential medical services, particularly when it comes to caring for their teeth and other oral tissues.

7 Aug 2015

Hedgehog blockade promising in myeloid malignancies

Phase I trial results published in The Lancet Haematology show that the hedgehog signalling pathway antagonist PF-04449913 is tolerable and has activity in patients with haematological cancers.

5 Aug 2015

Oral contraceptives give long-term protection against endometrial cancer, shows study

Use of oral contraceptives, even for just a few years, gives substantial long-term protection against endometrial cancer, and the longer the pill is used the greater the reduction in risk, according to a detailed re-analysis of all the available evidence, published in The Lancet Oncology journal.

5 Aug 2015

Pharmaxis, Synairgen partner to develop LOXL2 inhibitor to treat idiopathic pulmonary fibrosis

Australian pharmaceutical company Pharmaxis Ltd and UK biotechnology company Synairgen plc today announced they have entered into a research collaboration to develop a selective inhibitor to the lysyl oxidase type 2 enzyme (LOXL2) to treat the fatal lung disease idiopathic pulmonary fibrosis (IPF).

5 Aug 2015

Gastrostomy methods equivalent in amyotrophic lateral sclerosis

The ProGas study results show that three methods of gastrostomy are equally good in terms of complications and survival in patients with amyotrophic lateral sclerosis.

4 Aug 2015

NYUCD awarded $1.7M Health Resources and Service Administration training grant

New York University College of Dentistry has been awarded a five-year, $1.7M Health Resources and Service Administration training grant entitled, "Preparing the Future Dental Workforce for Underserved Young Child and Adolescent Populations ("Preparing the Future").

4 Aug 2015

Prokarium receives funding to complete pre-clinical development of new Chlamydia vaccine

Prokarium Ltd, a biotechnology company developing transformational oral vaccines, today announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.

4 Aug 2015

Oral News and Research

Ardelyx reports net income of $9.0 million for second quarter 2015

Findings may lead to more accurate diagnostic test, possible vaccine for oral and genital herpes

Study finds no added benefit for insulin degludec and liraglutide in type 2 diabetes

Griffith research aims to combat tooth decay problems in Australian children

IADR/AADR reports include critical review of diet, dental caries and health policy interventions

Meta-analysis confirms oral contraceptives reduce endometrial cancer risk

Instrumentation Laboratory announces European release of HemosIL Rivaroxaban Testing Solution

Flowonix Medical's new Patient Therapy Controller approved for market release

Lexicon Pharmaceuticals' revenues decrease to $0.4 million in second quarter 2015

Passionate kissing not the norm in most cultures, research finds

Researcher reveals link between inflammatory response of neutrophils and spread of oral cancer

Study sheds light on Avoidant/Restrictive Food Intake Disorder

Investigational topical drug shows promise in patients with early stage cutaneous T cell lymphoma

Grant program aims to provide oral health care to underserved people facing substance abuse issues

Hedgehog blockade promising in myeloid malignancies

Oral contraceptives give long-term protection against endometrial cancer, shows study

Pharmaxis, Synairgen partner to develop LOXL2 inhibitor to treat idiopathic pulmonary fibrosis

Gastrostomy methods equivalent in amyotrophic lateral sclerosis

NYUCD awarded $1.7M Health Resources and Service Administration training grant

Prokarium receives funding to complete pre-clinical development of new Chlamydia vaccine

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News